Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Targeting Interleukin-2 to the Bone Marrow Stroma for Therapy of Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation

Christoph Schliemann, MD, Katrin Gutbrodt, PhD, Andrea Kerkhoff, MD, Michele Pohlen, MD, Stefanie Wiebe, MD, Gerda Silling, MD, Linus Angenendt, Torsten Kessler, MD, Rolf M Mesters, MD, Leonardo Giovannoni, PhD, Michael Schäfers, MD, Bianca Altvater, PhD, Claudia Rössig, MD, Inga Grünewald, MD, Eva Wardelmann, MD, Gabriele Köhler, MD, Dario Neri, PhD, Matthias Stelljes, MD, Wolfgang E Berdel, MD

Blood (2014) 124 (21): 980.

https://doi.org/10.1182/blood.V124.21.980.980

Published: 2014

Journal Articles

Control of Multidrug Resistant Pseudomonas Aeruginosa through Hospital Construction Design and Extensive Environmental and Clinical Surveillance in an Allogeneic Transplantat Unit

Annelene Kossow, MD, Frank Kipp, MD, Gerda Silling, MD, Andreas H Groll, MD, Claudia Rössig, MD, Heribert Jürgens, MD, Alexander Mellmann, MD, Helge Karch, MD, Wolfgang E Berdel, MD, Matthias Stelljes, MD

Blood (2014) 124 (21): 1137.

https://doi.org/10.1182/blood.V124.21.1137.1137

Published: 2014

Journal Articles

Comparison Of Different Pretransplant Predictive Scores In Patients With Refractory Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation Including Highdose Melphalan: Results Of a Double-Center Observational Study

Nina Kristin Steckel, M.D., Markus Ditschkowski, MD, Christoph Groth, M.D., Gerda Silling, MD, U. Krug, MD, Rudolf Trenschel, MD, Hellmut Ottinger, MD, Wolfgang E Berdel, MD, Michael Koldehoff, MD, Ahmet H. Elmaagacli, Dietrich Beelen, MD, Matthias Stelljes, MD

Blood (2013) 122 (21): 4525.

https://doi.org/10.1182/blood.V122.21.4525.4525

Published: 2013

Journal Articles

Acute Myeloid Leukemia: Longterm Outcome Predicted by Age and Genetic Groups

Thomas Buchner, MD, Wolfgang E. Berdel, MD, Utz Krug, Claudia Haferlach, MD, Susanne Schnittger, PhD, Matthias Stelljes, MD, Gerda Silling, MD, Peter Staib, MD, Andreas Grueneisen, MD, Albrecht Reichle, Leopold Balleisen, MD, Hartmut Eimermacher, MD, Aristoteles Giagounidis, MD, Herbert Rasche, MD, Eva Lengfelder, MD, Cristina Sauerland, MSc, Achim Heinecke, PhD, Bernhard Josef Woermann, MD, Wolfgang Hiddemann, MD, PhD

Blood (2012) 120 (21): 1509.

https://doi.org/10.1182/blood.V120.21.1509.1509

Published: 2012

Journal Articles

Dose Escalation of Caspofungin for Invasive Aspergillosis - A Phase II Trial

O. A Cornely, J. J Vehreschild, M. J Rüping, S. Schwartz, C. Heussel, Gerda Silling, MD, J. Franklin, F. Farowski, T. Lehrnbecher, A. J Ullmann, A. Groll, Meinolf Karthaus

Blood (2010) 116 (21): 2309.

https://doi.org/10.1182/blood.V116.21.2309.2309

Published: 2010

Journal Articles

Immunological Intervention Triggered by Decreasing CD34 + Lineage-Specific Donor Cell Chimerism to Prevent Relapse of Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

Felix Rosenow, Gerda Silling, MD, Berkemeier Almut, MD, Carsten Mueller-Tidow, MD, Steffen Koschmieder, MD, Guido Bisping, MD, Utz Krug, MD, Thomas Buechner, MD, Wolfgang E Berdel, MD, Joachim Kienast, MD, Matthias Stelljes, MD

Blood (2009) 114 (22): 3317.

https://doi.org/10.1182/blood.V114.22.3317.3317

Published: 2009

Journal Articles

Forodesine in Patients with Refractory/Relapsed T-ALL Can Induce Prolonged Stable Remission with Minimal Toxicity before and after Allogeneic Hematopoietic Stem Cell Transplantation.

Mattias Stelljes, MD, Joachim Kienast, MD, Björna Berning, MD, Nicola Gokbuget, MD, Dieter Hoelzer, MD, Gerda Silling, MD, Wolfgang E. Berdel, MD, Gary Van Houten Dahl, MD, Debra Schissel, RN, Molly Hemenway, PNP, Lia Gore, MD

Blood (2006) 108 (11): 5340.

https://doi.org/10.1182/blood.V108.11.5340.5340

Published: 2006

Journal Articles

Noninvasive Assessment of Intestinal Graft-Versus-Host Disease Activity by 18F-Fluorodeoxyglucose Positron Emission Tomography.

Matthias Stelljes, MD, Jorn Albring, MD, Sven Hermann, MD, Christopher Poremba, MD, Gabiele Kohler, MD, Christoph Bremer, MD, Thorsten Kucharzik, MD, Gerda Silling, MD, Wolfgang E. Berdel, MD, Otmar Schober, MD, Michael Schafers, MD, Joachim Kienast, MD

Blood (2006) 108 (11): 3230.

https://doi.org/10.1182/blood.V108.11.3230.3230

Published: 2006

Journal Articles

Conditioning with 8 Gy Total Body Irradiation and Fludarabine for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia: Projected 4-Year Update.

Matthias Stelljes, MD, Martin Bornhaeuser, MD, Matthias Kroger, MD, Joerg Beyer, MD, Maria C. Sauerland, Achim Heinecke, PhD, Bjorna Berning, MD, Christian Scheffold, MD, Gerda Silling, MD, Thomas Buchner, MD, Andreas Neubauer, MD, Axel Arthur Fauser, MD, Gerhard Ehninger, MD, Wolfgang E. Berdel, MD, Joachim Kienast, MD

Blood (2006) 108 (11): 3016.

https://doi.org/10.1182/blood.V108.11.3016.3016

Published: 2006

NARROW

Targeting Interleukin-2 to the Bone Marrow Stroma for Therapy of Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation

Control of Multidrug Resistant Pseudomonas Aeruginosa through Hospital Construction Design and Extensive Environmental and Clinical Surveillance in an Allogeneic Transplantat Unit

Comparison Of Different Pretransplant Predictive Scores In Patients With Refractory Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation Including Highdose Melphalan: Results Of a Double-Center Observational Study

Acute Myeloid Leukemia: Longterm Outcome Predicted by Age and Genetic Groups

Dose Escalation of Caspofungin for Invasive Aspergillosis - A Phase II Trial

Immunological Intervention Triggered by Decreasing CD34 + Lineage-Specific Donor Cell Chimerism to Prevent Relapse of Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

Forodesine in Patients with Refractory/Relapsed T-ALL Can Induce Prolonged Stable Remission with Minimal Toxicity before and after Allogeneic Hematopoietic Stem Cell Transplantation.

Noninvasive Assessment of Intestinal Graft-Versus-Host Disease Activity by 18F-Fluorodeoxyglucose Positron Emission Tomography.

Conditioning with 8 Gy Total Body Irradiation and Fludarabine for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia: Projected 4-Year Update.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only